1. Home
  2. ACTG vs XOMA Comparison

ACTG vs XOMA Comparison

Compare ACTG & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTG
  • XOMA
  • Stock Information
  • Founded
  • ACTG 1993
  • XOMA 1981
  • Country
  • ACTG United States
  • XOMA United States
  • Employees
  • ACTG N/A
  • XOMA N/A
  • Industry
  • ACTG Multi-Sector Companies
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACTG Miscellaneous
  • XOMA Health Care
  • Exchange
  • ACTG Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • ACTG 363.5M
  • XOMA 300.5M
  • IPO Year
  • ACTG 1996
  • XOMA N/A
  • Fundamental
  • Price
  • ACTG $3.73
  • XOMA $24.76
  • Analyst Decision
  • ACTG
  • XOMA Strong Buy
  • Analyst Count
  • ACTG 0
  • XOMA 2
  • Target Price
  • ACTG N/A
  • XOMA $69.50
  • AVG Volume (30 Days)
  • ACTG 263.8K
  • XOMA 46.8K
  • Earning Date
  • ACTG 05-08-2025
  • XOMA 05-13-2025
  • Dividend Yield
  • ACTG N/A
  • XOMA N/A
  • EPS Growth
  • ACTG N/A
  • XOMA N/A
  • EPS
  • ACTG N/A
  • XOMA N/A
  • Revenue
  • ACTG $222,414,000.00
  • XOMA $42,909,000.00
  • Revenue This Year
  • ACTG $141.36
  • XOMA $24.96
  • Revenue Next Year
  • ACTG N/A
  • XOMA $26.75
  • P/E Ratio
  • ACTG N/A
  • XOMA N/A
  • Revenue Growth
  • ACTG 65.22
  • XOMA 638.41
  • 52 Week Low
  • ACTG $2.70
  • XOMA $18.35
  • 52 Week High
  • ACTG $5.74
  • XOMA $35.00
  • Technical
  • Relative Strength Index (RSI)
  • ACTG 57.69
  • XOMA 50.43
  • Support Level
  • ACTG $3.58
  • XOMA $24.50
  • Resistance Level
  • ACTG $3.87
  • XOMA $27.00
  • Average True Range (ATR)
  • ACTG 0.13
  • XOMA 1.38
  • MACD
  • ACTG 0.00
  • XOMA -0.27
  • Stochastic Oscillator
  • ACTG 36.59
  • XOMA 15.59

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: